Sorry, you need to enable JavaScript to visit this website.
dave_denton_300x170.jpg

Dave Denton

Chief Financial Officer and Executive Vice President

Dave M. Denton is the Chief Financial Officer and Executive Vice President for Pfizer. Dave is a member of Pfizer’s Executive Leadership Team (ELT), providing strategic global financial leadership. Dave leads the corporate finance functions including audit, treasury, tax, insurance, operations planning and analysis (OP&A), corporate controllership, and business finance and analytics.

Dave has more than 25 years of finance and operational expertise, including more than 20 years in the healthcare sector. As a result, he brings to Pfizer a unique perspective on the role of payers, the needs of patients, and the rapidly evolving healthcare landscape.

Prior to joining Pfizer, Dave was the CFO and Executive Vice President of Lowe’s Companies Inc. He joined Lowes in 2018 and was responsible for all of Lowe’s financial functions and processes. This includes corporate finance and treasury, strategy, real estate, accounting, tax, internal audit and risk management.

Before joining Lowe's, he served as executive vice president and CFO of CVS Health, where he was responsible for all aspects of financial planning and management. Dave played a key role in CVS’s transformational journey from a retail pharmacy to the health solutions company it is today and led the full integration of Caremark into CVS. In December 2017, he played a pivotal role in one of the largest healthcare transactions in history when CVS acquired Aetna - structuring and negotiating the terms and financing for the transaction.

Before being named the CFO of CVS Health, Dave held several leadership roles at CVS, including Senior Vice President and Controller/Chief Accounting Officer. Prior to CVS, Dave was with the management consulting firm of Deloitte Touche Tohmatsu.

Dave earned a bachelor's degree in business administration from Kansas State University and an MBA from the Babcock Graduate School of Management at Wake Forest University. He serves on the board of Tapestry, Inc.

ab_headshot_2021_300x170.jpg
Dr. Albert Bourla

Chief Executive Officer and Chairman

Bill Carapezzi
Bill Carapezzi

Executive Vice President, Global Business Services and Transformation

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

angela_hwang_300X170_0.jpg
Angela Hwang

Chief Commercial Officer, President, Global Biopharmaceuticals Business

Media Name: rady-johnson300x170px.jpg
Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

Media Name: doug_profile_bio_2019_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik
Aamir Malik

Chief Business Innovation Officer, Executive Vice President

MikeMcDermott_300x170.jpg
Mike McDermott

Chief Global Supply Officer, Executive Vice President

william_pao_2_300x170.jpg
William Pao, M.D., Ph.D.

Chief Development Officer, Executive Vice President

payal_2021_300x170.jpg
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally-Susman-2022_300x170_2.jpg
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President

dave_denton_300x170.jpg

Dave Denton

Chief Financial Officer and Executive Vice President

Dave M. Denton is the Chief Financial Officer and Executive Vice President for Pfizer. Dave is a member of Pfizer’s Executive Leadership Team (ELT), providing strategic global financial leadership. Dave leads the corporate finance functions including audit, treasury, tax, insurance, operations planning and analysis (OP&A), corporate controllership, and business finance and analytics.

Dave has more than 25 years of finance and operational expertise, including more than 20 years in the healthcare sector. As a result, he brings to Pfizer a unique perspective on the role of payers, the needs of patients, and the rapidly evolving healthcare landscape.

Prior to joining Pfizer, Dave was the CFO and Executive Vice President of Lowe’s Companies Inc. He joined Lowes in 2018 and was responsible for all of Lowe’s financial functions and processes. This includes corporate finance and treasury, strategy, real estate, accounting, tax, internal audit and risk management.

Before joining Lowe's, he served as executive vice president and CFO of CVS Health, where he was responsible for all aspects of financial planning and management. Dave played a key role in CVS’s transformational journey from a retail pharmacy to the health solutions company it is today and led the full integration of Caremark into CVS. In December 2017, he played a pivotal role in one of the largest healthcare transactions in history when CVS acquired Aetna - structuring and negotiating the terms and financing for the transaction.

Before being named the CFO of CVS Health, Dave held several leadership roles at CVS, including Senior Vice President and Controller/Chief Accounting Officer. Prior to CVS, Dave was with the management consulting firm of Deloitte Touche Tohmatsu.

Dave earned a bachelor's degree in business administration from Kansas State University and an MBA from the Babcock Graduate School of Management at Wake Forest University. He serves on the board of Tapestry, Inc.

ab_headshot_2021_300x170.jpg
Dr. Albert Bourla

Chief Executive Officer and Chairman

Bill Carapezzi
Bill Carapezzi

Executive Vice President, Global Business Services and Transformation

Media Name: mikael_dolsten300x170_2019_v3.jpg
Mikael Dolsten, M.D., Ph.D.

Chief Scientific Officer and President, Worldwide Research, Development and Medical of Pfizer Inc.

Media Name: lidia_fonseca300x170.jpg
Lidia Fonseca

Chief Digital and Technology Officer, Executive Vice President

angela_hwang_300X170_0.jpg
Angela Hwang

Chief Commercial Officer, President, Global Biopharmaceuticals Business

Media Name: rady-johnson300x170px.jpg
Rady Johnson

Chief Compliance, Quality and Risk Officer, Executive Vice President

Media Name: doug_profile_bio_2019_300x170.jpg
Doug Lankler

General Counsel, Executive Vice President

Aamir Malik
Aamir Malik

Chief Business Innovation Officer, Executive Vice President

MikeMcDermott_300x170.jpg
Mike McDermott

Chief Global Supply Officer, Executive Vice President

william_pao_2_300x170.jpg
William Pao, M.D., Ph.D.

Chief Development Officer, Executive Vice President

payal_2021_300x170.jpg
Payal Sahni Becher

Chief People Experience Officer, Executive Vice President

Sally-Susman-2022_300x170_2.jpg
Sally Susman

Chief Corporate Affairs Officer, Executive Vice President